PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of R&D, Medaman BV, Geel, Belgium.\', \'Department of Real-World Evidence, Open Health, Marlow, UK.\', \'DDO Strategic Services, LLC, Tucson AZ, US.\', \'Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.\', \'Faculty of Medical & Health Sciences, Ghent University, Ghent, Belgium.\', \'Department of Medical Data Management, AZ Delta, Roeselare, Belgium.\', \'Department of Nephrology and Infectious Diseases, AZ Sint-Jan Brugge-Oostende AV, Bruges, Belgium.\', \'Department of Pneumology and Respiratory Oncology, AZ Vesalius, Tongeren, Belgium.\', \'Medical Department, RZ Heilig Hart, Tienen, Belgium.\', \'Sergy Haut, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/21645515.2021.1920271
?:hasPublicationType
?:journal
  • Human vaccines & immunotherapeutics
is ?:pmid of
?:pmid
?:pmid
  • 34047686
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all